系统性硬化症真皮成纤维细胞通过LOXL-4诱导皮肤纤维化:三维仿皮肤组织新证据
研究将8例系统性硬化症(SSc)真皮成纤维细胞与6例正常真皮成纤维细胞分别嵌入三维仿皮肤组织模型(HSE和SAS),发现SSc成纤维细胞导致基质增厚、胶原沉积与交联增加、LOXL4表达上调及固有免疫信号激活,敲低LOXL4可抑制纤维化表型,提示LOXL-4在SSc皮肤纤维化中起关键作用。
要点
- SSc真皮成纤维细胞在三维皮肤模型中诱导基质增厚、胶原沉积和交联增加。
- SSc模型中LOXL4表达上调,敲低LOXL4可抑制刚性、收缩和α-SMA表达。
- HSE与SAS可作为互补的体外模型研究SSc纤维化机制。
核心结论
- SSc真皮成纤维细胞通过上调LOXL-4促进胶原交联和基质刚性,从而驱动皮肤纤维化。
研究设计与样本
- 将8例SSc患者来源真皮成纤维细胞和6例正常真皮成纤维细胞分别嵌入生物工程人类皮肤等效物(HSE)和自组装基质组织(SAS)两种三维模型。
主要发现
- 含SSc成纤维细胞的SAS较含正常成纤维细胞的SAS显示基质厚度、胶原沉积和白介素-6分泌增加(P < 0.05)。
- 在HSE中,SSc成纤维细胞使胶原呈现更成熟和排列整齐的纤维结构(P < 0.05)。
- 两种组织模型中,SSc成纤维细胞均导致基质刚性增强、胶原交联增加(P < 0.05)、LOXL4表达上调(P < 0.01)及固有免疫信号基因表达。
- 在HSE中敲低LOXL4可抑制SSc成纤维细胞的刚性、收缩和α-平滑肌肌动蛋白表达,在SAS中抑制TGFβ诱导的ECM聚集和胶原交联。
临床怎么用
- HSE和SAS三维模型可用于体外研究SSc纤维化机制及评估靶向LOXL-4的干预措施。
局限性
- 原文指出SSc体外人类皮肤模型系统缺乏是有效治疗开发的局限,但未具体说明本研究的其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Systemic sclerosis (SSc) is a clinically heterogeneous disease characterized by increased collagen accumulation and skin stiffness. Our previous work has demonstrated that transforming growth factor β (TGFβ) induces extracellular matrix (ECM) modifications through lysyl oxidase-like 4 (LOXL-4), a collagen crosslinking enzyme, in bioengineered human skin equivalents (HSEs) and self-assembled stromal tissues (SAS). We undertook this study to investigate cutaneous fibrosis and the role of LOXL-4 in SSc pathogenesis using HSEs and SAS. METHODS: SSc-derived dermal fibroblasts (SScDFs; n = 8) and normal dermal fibroblasts (NDFs; n = 6) were incorporated into HSEs and SAS. These 3-dimensional skin-like microenvironments were used to study the effects of dysregulated LOXL-4 on ECM remodeling, fibroblast activation, and response to TGFβ stimulation. RESULTS: SScDF-containing SAS showed increased stromal thickness, collagen deposition, and interleukin-6 secretion compared to NDF-containing SAS (P < 0.05). In HSE, SScDFs altered collagen as seen by a more mature and aligned fibrillar structure (P < 0.05). With SScDFs, enhanced stromal rigidity with increased collagen crosslinking (P < 0.05), up-regulation of LOXL4 expression (P < 0.01), and innate immune signaling genes were observed in both tissue models. Conversely, knockdown of LOXL4 suppressed rigidity, contraction, and α-smooth muscle actin expression in SScDFs in HSE, and TGFβ-induced ECM aggregation and collagen crosslinking in SAS. CONCLUSION: A limitation to the development of effective therapeutics in SSc is the lack of in vitro human model systems that replicate human skin. Our findings demonstrate that SAS and HSE can serve as complementary in vitro skin-like models for investigation of the mechanisms and mediators that drive fibrosis in SSc and implicate a pivotal role for LOXL-4 in SSc pathogenesis.
引用
- Huang M, Cai G, Baugh LM, et al. Systemic Sclerosis Dermal Fibroblasts Induce Cutaneous Fibrosis Through Lysyl Oxidase-like 4: New Evidence From Three-Dimensional Skin-like Tissues. Arthritis Rheumatol. 2020. PMID: 31705627. doi:10.1002/art.41163
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。